Serial Number | 97855620 |
Word Mark | SUTRO |
Filing Date | Friday, March 24, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, July 16, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 21, 2024 |
Goods and Services | Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations |
Description of Mark | The mark consists of the word SUTRO with the letter O displayed as an elongated crescent with a circle placed in the open portion of the crescent. |
Goods and Services | Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer, cardiovascular, hematopoietic, central nervous system, autoimmune, infectious, skin and skin structure, bone, genetic, endocrine or metabolic diseases, disorders, and conditions; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, April 16, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, April 16, 2023 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, April 16, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Sutro Biopharma, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Party Name | Sutro Biopharma, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Event Date | Event Description |
Tuesday, March 28, 2023 | NEW APPLICATION ENTERED |
Sunday, April 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, April 18, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, December 19, 2023 | ASSIGNED TO EXAMINER |
Wednesday, December 20, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, December 20, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, December 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 19, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, April 16, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, April 16, 2024 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, April 16, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, April 17, 2024 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, May 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 21, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, May 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 16, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, April 17, 2024 | ASSIGNED TO LIE |
Wednesday, April 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |